Attachment 3 Quote Sheet.xlsx

XLSX spreadsheet 17 KB Posted

Attached to
FY26 Lab Consolidation for Coagulation CPRR Effort
Solicitation number
HT941026Q2004
Issued by

About this file

This is a quote sheet template for RFQ #HT941026Q2004, a Request for Quotation issued by the Defense Health Agency's Healthcare Contracting Division - West for FY26 Lab Consolidation for Coagulation CPRR (Cost Per Reportable Result) Effort. The quote sheet requires offerors to provide pricing on a per-test basis for coagulation analyzer services supporting military treatment facilities. The contract structure includes a base period from October 1, 2026 through September 30, 2027, followed by four one-year option periods (October 2027 through September 2031) and a six-month extension option (October 2031 through March 2032).

The quote sheet lists 21 distinct coagulation tests with estimated annual test counts, including Prothrombin Time (48,463 tests), Activated Partial Thromboplastin Time (27,685 tests), Fibrinogen (5,007 tests), D-Dimer (11,435 tests), and specialized assays such as Factor VIII through Factor XI, Antithrombin III, and Von Willebrand Factor Antigen. The total estimated annual volume across all tests is 99,299 reportable results. Offerors must provide a cost per reportable result for each test type and acknowledge receipt of any solicitation amendments. Quotes must remain firm for 60 calendar days from the specified receipt date, and the offeror must agree to all terms, conditions, and provisions of the solicitation. The total evaluated price (base plus four options) should be calculated and entered on the cover sheet.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Coag Cover Sheet

Attachment 3 - Quote Sheet
RFQ #:HT941026Q2004
Reference Number:
Requirement:DHA HCD-W Coagulation CPRR
Contracting Office:DHA Healhtcare Contracting Division - West

Total Evaluated Price (Base + 4 Options): $ - 0

Quoter Name:
Street Address:
City, State, ZIP:
Unique Entity ID:
CAGE Code:
Point of Contact:
Phone Number:
Email Address:
The Offeror acknowledges receipt of the following amendments to the solicitation:
Amendment No.:Date:Amendment No.:Date:
Amendment No.:Date:Amendment No.:Date:
Amendment No.:Date:Amendment No.:Date:
Amendment No.:Date:Amendment No.:Date:
Amendment No.:Date:Amendment No.:Date:
Amendment No.:Date:Amendment No.:Date:

The Offeror agrees with all terms, conditions, and provisions included in the solicitation and agrees to furnish any or all items set forth or otherwise identified above subject to the terms and conditions specified in the solicitation.

The Offeror agrees to hold the prices in its quote firm for 60 calendar days from the date specified for receipt of quotes.

Person Authorized to Sign Quote:
Signature:
Date:

Payment Terms:

Coag Quote Sheet

HT941026Q2004 Attachment 3 - Quote Sheet
RFQ #:HT941026Q2004
Reference Number:
Requirement:DHA HCD-W Coagulation CPRR
Contracting Office:DHA Healhtcare Contracting Division - West
TestEstimated Annual Test CountCost Per Reportable Result10/01/2026 - 09/30/2027 Price Base Period10/01/2027 - 09/30/2028 Price Option Period One10/01/2028 - 09/30/2029 Price Option Period Two10/01/2029 - 09/30/2030 Price Option Period Three10/01/2029 - 09/30/2030 Price Option Period Four10/01/2031 - 03/31/2032
Price Option 6-Mo ExtensionTotals
Prothrombin Time (PT)48463$0.00
Activated Partial Thromboplastin Time (APTT)27685$0.00
Fibrinogen5007$0.00
D-Dimer11435$0.00
Heperin3484$0.00
INR500$0.00
Lupus Anticoagulant150$0.00
Factor VIII Assay451$0.00
DIC Panel1800$0.00
Heparin (Low Molecular Weight)60$0.00
Patient Thrombin Time21$0.00
Mixing Studies30$0.00
Reptilase Time10$0.00
Factor V Assay66$0.00
Factor VII Assay27$0.00
Factor IX Assay22$0.00
Factor X Assay14$0.00
Factor XI Assay14$0.00
Antithrombin III39$0.00
Von Willebrand Factor Antigen16$0.00
Factor II Assay5$0.00
Totals:99299$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

File details come from the government source that posted it. Updated .